National Medicines Symposium 2024 speakers (L to R): Steve Waller, Professor Jennifer Martin, Professor Libby Roughead, Tegan Taylor[/caption]
This CPD activity is sponsored by Reckitt. All content is the true, accurate and independent opinion of the speakers and the views expressed are entirely their own.[/caption]
Full continued dispensing returns in Tasmania, plus other big announcements
Continued dispensing arrangements have expanded in Tasmania, while travel vaccines and a UTI pilot were announced in the ACT.
CAL D has changed awareness of antimicrobial resistance
A pharmacist shares how the recently introduced Cautionary Advisory Label (CAL D) for antibiotics has changed patient perceptions, and behaviour, towards antibiotics.
Continued Dispensing arrangements change on Friday
The Pharmaceutical Benefits Advisory Committee has announced new ongoing arrangements for Continued Dispensing.
Supporting patients through GLP-1 agonist cessation effects
Glucagon-like peptide 1 (GLP-1) agonists, traditionally used to manage type 2 diabetes, have been increasingly prescribed off-label for weight loss.
There are four GLP-1 agonist...
Unlocking access: Downscheduling changes in 2021
After years of little movement in downscheduling of medicines in Australia, 2021 will usher in a flurry of activity – but Appendix M remains conspicuously empty.
So long SABA, hello ICS/LABA says respiratory expert
SABA overuse is undermining asthma control. This National Asthma Week, pharmacists should inform patients about the risks.
